Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
FRATTAROLI JOSEPH
Date
Name
Symbol
Type
Security
Shares
Price
Value
Ownership
Reported
05/19/2022
Inhibikase Therapeutics, Inc.
Purchase
Common Stock
3.9k
$0.64
$2.5k
05/19/2022
03/07/2022
Inhibikase Therapeutics, Inc.
Grant
Stock Option (right to buy)
62.5k
$1.07
$66.9k
03/07/2022
03/07/2022
Inhibikase Therapeutics, Inc.
Grant
Stock Option (right to buy)
62.5k
$1.07
$66.9k
03/07/2022
12/28/2020
Inhibikase Therapeutics, Inc.
Conversion
Common Stock
44.1k
$10.00
$441.4k
By Flagship Consulting, Inc.
12/22/2020
12/28/2020
Inhibikase Therapeutics, Inc.
Conversion
Convertible Note
0
$10.00
$0
By Flagship Consulting, Inc.
12/22/2020
12/22/2020
Inhibikase Therapeutics, Inc.
Grant
Stock Option (right to buy)
100k
$10.00
$1000k
12/22/2020
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy